• Jin Medical International will hold a shareholder meeting in Changzhou City, China on July 9, 2026.
• Investors will vote on increasing Class B ordinary share voting power to 800 votes per share from 30.
• Agenda includes repurchasing 3,769,057 Class A ordinary shares from Jolly Harmony, with the shares to be cancelled.
• Shareholders will also vote on issuing 3,769,057 Class B ordinary shares to Jolly Harmony at a price tied to a 90-day VWAP.
• Items include a major authorized share capital increase, plus an acquisition of control of Beijing Tongsheng with issuance of 64,186,456 Class A shares at USD 1.64.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jin Medical International Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-073135), on June 29, 2026, and is solely responsible for the information contained therein.